Cargando…

Management of Aggressive Non-Hodgkin Lymphomas in the Pediatric, Adolescent, and Young Adult Population: An Adult vs. Pediatric Perspective

SIMPLE SUMMARY: This review details the diagnosis and treatment of primary non-Hodgkin lymphoma (NHL) in the pediatric and adolescent population. We also describe treatment modalities such as hematopoietic stem cell transplantation for relapsed or refractory NHL in patients that fail or do not respo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sheikh, Irtiza N., Elgehiny, Amr, Ragoonanan, Dristhi, Mahadeo, Kris M., Nieto, Yago, Khazal, Sajad
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9221186/ https://www.ncbi.nlm.nih.gov/pubmed/35740580 http://dx.doi.org/10.3390/cancers14122912

Ejemplares similares

The Evolution of Chimeric Antigen Receptor T-Cell Therapy in Children, Adolescents and Young Adults with Acute Lymphoblastic Leukemia
por: Ragoonanan, Dristhi, et al.
Publicado: (2022)

Post-Transplant Cyclophosphamide after Matched Sibling and Unrelated Donor Hematopoietic Stem Cell Transplantation in Pediatric Patients with Acute Myeloid Leukemia
por: Sheikh, Irtiza N., et al.
Publicado: (2022)

Cardiac Relapse of Acute Lymphoblastic Leukemia Following Hematopoietic Stem Cell Transplantation: A Case Report and Review of Literature
por: Sheikh, Irtiza N., et al.
Publicado: (2021)

Characteristics and Outcomes of Children, Adolescents and Young Adults with Relapsed/Refractory Non-Hodgkin Lymphoma Undergoing Autologous Stem Cell Transplant
por: Nieto, Yago, et al.
Publicado: (2023)

A multicenter study of ICU resource utilization in pediatric, adolescent and young adult patients post CAR-T therapy
por: Ragoonanan, Dristhi, et al.
Publicado: (2022)

Complete remission in refractory acute lymphoblastic leukemia using blinatumomab after failure of response to CD‐19 chimeric antigen receptor T‐cell therapy
por: Tambaro, Francesco Paolo, et al.
Publicado: (2020)

Transfusion reactions in pediatric and adolescent young adult haematology oncology and immune effector cell patients
por: Kohorst, Mira A., et al.
Publicado: (2020)

Classical Hodgkin Lymphoma: From Past to Future—A Comprehensive Review of Pathophysiology and Therapeutic Advances
por: Munir, Faryal, et al.
Publicado: (2023)

Blastic plasmacytoid dendritic cell neoplasm: a comprehensive review in pediatrics, adolescents, and young adults (AYA) and an update of novel therapies
por: Cuglievan, Branko, et al.
Publicado: (2023)

Prior COVID-19 infection may increase risk for developing endothelial dysfunction following hematopoietic cell transplantation
por: Ariagno, Sydney, et al.
Publicado: (2023)

Immune Effector Cell Associated Neurotoxicity (ICANS) in Pediatric and Young Adult Patients Following Chimeric Antigen Receptor (CAR) T-Cell Therapy: Can We Optimize Early Diagnosis?
por: Brown, Brandon Douglas, et al.
Publicado: (2021)

Chimeric Antigen Receptor, Teamwork, Education, Assessment, and Management (CAR-TEAM): A Simulation-Based Inter-professional Education (IPE) Intervention for Management of CAR Toxicities
por: Harden, Avis, et al.
Publicado: (2020)

IMMU-07. IMMUNE EFFECTOR CELL ASSOCIATED NEUROTOXICITY (ICANS) AMONG PEDIATRIC AND AYA PATIENTS: MD ANDERSON CANCER CENTER EXPERIENCE
por: Brown, Brandon, et al.
Publicado: (2020)

Automated Capture and Analysis of Circulating Tumor Cells in Pediatric, Adolescent and Young Adult Patients with Central Nervous System Tumors
por: Zaky, Wafik, et al.
Publicado: (2023)

The Organ Trail: A Review of Biomarkers of Organ Failure
por: Dao, Long, et al.
Publicado: (2020)

IL12 immune therapy clinical trial review: Novel strategies for avoiding CRS-associated cytokines
por: Jia, Zhiliang, et al.
Publicado: (2022)

Treatment patterns and outcomes in adolescents and young adults with Hodgkin lymphoma in pediatric versus adult centers: An IMPACT Cohort Study
por: Gupta, Sumit, et al.
Publicado: (2020)

DIPG-60. PILOT STUDY OF CIRCULATING TUMOR CELLS IN PEDIATRIC HIGH GRADE BRAIN TUMORS
por: Zaky, Wafik, et al.
Publicado: (2020)

Using the MDASI-Adolescent for Early Symptom Identification and Mitigation of Symptom Impact on Daily Living in Adolescent and Young Adult Stem Cell Transplant Patients
por: Sheikh, Irtiza N., et al.
Publicado: (2021)

Proteomic Profiles and Biological Processes of Relapsed vs. Non-Relapsed Pediatric Hodgkin Lymphoma
por: Repetto, Ombretta, et al.
Publicado: (2020)

Improved outcomes of high-risk relapsed Hodgkin lymphoma patients after high-dose chemotherapy: a 15-year analysis
por: Nieto, Yago, et al.
Publicado: (2021)

Defining the Inflammatory Plasma Proteome in Pediatric Hodgkin Lymphoma
por: Agrusa, Jennifer E., et al.
Publicado: (2020)

Non-Hodgkin lymphoma after pediatric kidney transplantation
por: Grenda, Ryszard
Publicado: (2021)

The circuitry of the tumor microenvironment in adult and pediatric Hodgkin lymphoma: cellular composition, cytokine profile, EBV, and exosomes
por: Nagpal, Poonam, et al.
Publicado: (2020)

Pixantrone for the treatment of adult patients with relapsed or refractory aggressive non-Hodgkin B-cell lymphomas
por: Volpetti, Stefano, et al.
Publicado: (2014)

Prevalence of Sleep Disturbances in Pediatric Cancer Patients and Their Diagnosis and Management
por: Sheikh, Irtiza N., et al.
Publicado: (2021)

Ultrasound presentation of abdominal non-Hodgkin lymphomas in pediatric patients
por: Brodzisz, Agnieszka, et al.
Publicado: (2013)

The New Treatment Methods for Non-Hodgkin Lymphoma in Pediatric Patients
por: Derebas, Justyna, et al.
Publicado: (2022)

CAR-T Cell Therapy in the Treatment of Pediatric Non-Hodgkin Lymphoma
por: Ostojska, Magdalena, et al.
Publicado: (2023)

Programmed cell death ligand 1 expression in aggressive pediatric non-Hodgkin lymphomas: frequency, genetic mechanisms, and clinical significance
por: Fisher, Kevin E., et al.
Publicado: (2022)

Radiation Therapy Across Pediatric Hodgkin Lymphoma Research Group Protocols: A Report From the Staging, Evaluation, and Response Criteria Harmonization (SEARCH) for Childhood, Adolescent, and Young Adult Hodgkin Lymphoma (CAYAHL) Group
por: Hall, Matthew D., et al.
Publicado: (2022)

Multiple sclerosis and risk of young-adult-onset Hodgkin lymphoma
por: Montgomery, Scott, et al.
Publicado: (2016)

Scientific techniques in adolescent and young adult classic Hodgkin lymphoma
por: Maura, Francesco, et al.
Publicado: (2023)

Distribution of hospital care among pediatric and young adult Hodgkin lymphoma survivors—A population‐based cohort study from Sweden and Denmark
por: Glimelius, Ingrid, et al.
Publicado: (2019)

Non-Hodgkin Lymphoma Secondary to Hodgkin Lymphoma in an Adult Patient With Nijmegen Breakage Syndrome
por: Braitsch, Krischan, et al.
Publicado: (2018)

Targeted Therapies for the Treatment of Pediatric Non-Hodgkin Lymphomas: Present and Future
por: Sorge, Caryn E., et al.
Publicado: (2016)

Tuberculosis Coexistence in Pediatric Hodgkin’s Lymphoma: A Tropical Country Experience
por: Padma, Maneya, et al.
Publicado: (2020)

P086: Advancing Pediatric Hodgkin Lymphoma Research Through NODAL
por: Flerlage, Jamie E., et al.
Publicado: (2022)

Promising drugs and treatment options for pediatric and adolescent patients with Hodgkin lymphoma
por: De Re, Valli, et al.
Publicado: (2022)

Non-Hodgkin’s Lymphoma Presenting as Esophageal Stenosis in a Pediatric Patient
por: Lee, Jeffrey, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_f3ufapuvtvdkqgsr8h3praqlp6